KORU Medical Systems, Inc. $KRMD

What the company doesAI summary of filing

KORU Medical develops, manufactures, and commercializes mechanical subcutaneous infusion devices for drug delivery, primarily the FREEDOM System (including syringe drivers, needle sets, and tubing) used to administer immunoglobulin therapies for primary immunodeficiency diseases and other conditions. The company generates revenue from three sources: domestic core sales (US and Canada), international core sales, and pharma services including clinical trials and non-recurring engineering services for biopharmaceutical companies developing new drugs. KORU manufactures its pump products at its Mahwah, New Jersey facility and sources consumables partly from an external contract manufacturer; it sells through a limited number of distributors (nine distributors representing approximately 77% of revenues) to specialty pharmacies, home infusion providers, and pharmaceutical companies. The company is revenue-generating and FDA-regulated, with its devices cleared or approved for delivery of multiple branded immunoglobulin products and other therapies. [10-K 2026-03-12]

Segments: FREEDOM System (syringe drivers and accessories), Domestic core (US and Canada), International core, Pharma services and clinical trials